Business
Anteris (ASX:AVR) share price drops 7% despite positive announcement
The Anteris Technologies Ltd (ASX: AVR) share price is plunging today despite the company declaring “outstanding” results from one of its medical products.
At the time of writing, shares in the medical technology company are trading at $11.9, down 7.67%. By comparison S&P/ASX All Ordinaries Index (ASX: XAO) is down 0.14%.
Anteris, formerly known as Admedus Ltd, focuses on designing and manufacturing heart valves. Its next-generation technology re-engineers xenograft tissue into pure collagen scaffold, helping surgeons replace valves for patients during surgery.
What did Anteris announce today?
The Anteris share price is not…
-
General11 hours agoUber driver says rideshare app tells workers to flout road rules as bill introduced
-
General7 hours agoPerson in potentially life-threatening condition after wall collapses in Brisbane’s West End
-
General12 hours agoBoard stacking allegations as RACP directors call snap meeting
-
General23 hours agoFollow the money. A radioactive farce of failed land purchases